Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The YAP1 gene encodes a potent new oncogene and stem cell factor. However, in some cancers, the YAP1 gene plays a role of tumor suppressor. At present, the gene and its products are intensely studied and its cDNAs are used as transgenes in cellular and animal models. Here, we report 4 new potential mRNA splicing isoforms of the YAP1 gene, bringing the total number of isoforms to 8. We detected all 8 YAP1 isoforms in a panel of human tissues and evaluated the expression of the longest isoform of YAP1 (YAP1-2δ) using Real Time PCR. All YAP1 isoforms are barely detectable in human leukocytes compared to fair levels of expression found in other human tissues. We analyzed the structure of the genomic region that gave rise to alternatively spliced YAP1 transcripts in different metazoans. We found that YAP1 isoforms, which utilize exon 6 emerged in evolution with the appearance of amniotes. Interestingly, 6 YAP1 isoforms, which contain the exon 5 extension, exon 6 or both would have their leucine zipper region disrupted in the predicted protein product, compared to the intact leucine zipper found in two YAP1 (α) isoforms. This observation has direct functional ramifications for YAP1 signaling. We also propose a normalized nomenclature for the mRNA splice variants of YAP1 gene, which should aid in the characterization of signaling differences among the potential protein products of the YAP1 gene.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Predicting coiled coils from protein sequences.
Lupas, A., Van Dyke, M., & Stock, J. (1991) · Science · doi:10.1126/science.252.5009.1162 · Cited by 3,953
The Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins
Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1988) · Science · doi:10.1126/science.3289117 · Cited by 3,443
Comparative Protein Structure Modeling of Genes and Genomes
Martí-Renom, M. A., Stuart, A. C., Fiser, A., Sánchez, R., Melo, F., & Šali, A. (2000) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.29.1.291 · Cited by 3,169 · cited 1×
“Structural models of putative leucine zippers of YAP1-1α isoform were built using the MODELLER software based on homology modeling (Marti-Renom et al., 2000).”
Yap1 acts downstream of α-catenin to control epidermal proliferation
Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D., Kreger, B. T., Vasioukhin, V., Avruch, J., Brummelkamp, T. R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.02.031 · Cited by 1,036 · cited 1×
“A number of studies reported over-expression of individual and different isoforms of YAP1 in cells and animals (e.g., Komuro et al., 2003; Hao et al., 2008; Oka et al., 2008; Muramatsu at al., 2011; Schlegelmilch et al., 2011).”
The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
Harvey, K., & Tapon, N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2070 · Cited by 628 · cited 2×
“The human YAP1 gene (NCBI GENE ID, 10413) is located on chromosome 11 at position q22 and the gene is frequently amplified in several human cancers including liver, breast, prostate and esophageal cancer (Sudol et al., 1995; Harvey and Tapon, 2007; Pan 2010).”
Chen, H. I., & Sudol, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7819 · Cited by 557 · cited 1×
“The WW domain mediates protein complexes with partners that contain a PPxY motif (where P is Proline, Y is Tyrosine and x is any amino acid) and these complexes are unusually prevalent among components of the Hippo tumor suppressor pathway (Chen and Sudol, 1995; Sudol and Harvey, 2010).”
BackgroundSelf-citationMechanism of specificity in the Fos-Jun oncoprotein heterodimer
O'Shea, E. K., Rutkowski, R., & Kim, P. S. (1992) · Cell · doi:10.1016/0092-8674(92)90145-3 · Cited by 422
The WW domain: a signalling site in dystrophin?
Bork, P., & Sudol, M. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90053-1 · Cited by 388
Self-citationSudol, M., Bork, P., Einbond, A., Kastury, K., Druck, T., Negrini, M., Huebner, K., & Lehman, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14733 · Cited by 342 · cited 1×
“The WW domain mediates protein complexes with partners that contain a PPxY motif (where P is Proline, Y is Tyrosine and x is any amino acid) and these complexes are unusually prevalent among components of the Hippo tumor suppressor pathway (Chen and Sudol, 1995; Sudol and Harvey, 2010).”
Self-citationThe Evolutionary History of YAP and the Hippo/YAP Pathway
Hilman, D., & Gat, U. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr065 · Cited by 166 · cited 1×
“In addition, we analyzed the evolutionary changes in the structure of the metazoan YAP1 orthologs (Hilman and Gat, 2011), with emphasis on exons 4, 5 and 6, the splicing of which generates the different isoforms of YAP1.”
BackgroundSelf-citation
Cited by
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Cunningham, R., & Hansen, C. G. (2022) · Clinical Science · doi:10.1042/cs20201474 · Cited by 326
Emerging roles of TEAD transcription factors and its coactivators in cancers
Pobbati, A. V., & Hong, W. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.23788 · Cited by 253
Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation
Yu, M., Peng, Z., Qin, M., Liu, Y., Wang, J., Zhang, C., Lin, J., Dong, T., Wang, L., Li, S., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.01.010 · Cited by 250
The Angiomotins – From discovery to function
Moleirinho, S., Guerrant, W., & Kissil, J. L. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.02.006 · Cited by 112
The Hippo signal transduction network in skeletal and cardiac muscle
Wackerhage, H., Del Re, D. P., Judson, R. N., Sudol, M., & Sadoshima, J. (2014) · Science Signaling · doi:10.1126/scisignal.2005096 · Cited by 92
Self-citationFramework to function: mechanosensitive regulators of gene transcription
Finch-Edmondson, M., & Sudol, M. (2016) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-016-0028-7 · Cited by 93
Self-citationAlternative splicing rewires Hippo signaling pathway in hepatocytes to promote liver regeneration
Bangru, S., Arif, W., Seimetz, J., Bhate, A., Chen, J., Rashan, E. H., Carstens, R. P., Anakk, S., & Kalsotra, A. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0129-2 · Cited by 85
Label-free quantitative proteomic analysis of the YAP/TAZ interactome
Kohli, P., Bartram, M. P., Habbig, S., Pahmeyer, C., Lamkemeyer, T., Benzing, T., Schermer, B., & Rinschen, M. M. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00339.2013 · Cited by 61
Metadata
- Authors
- Gaffney, C. J., Oka, T., Mazack, V., Hilman, D., Gat, U., Muramatsu, T., Inazawa, J., Golden, A., Carey, D. J., Farooq, A., Tromp, G., & Sudol, M.
- Venue
- Gene
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 509
- Issue
- 2
- Pages
- 215-222
- ISSN
- 0378-1119 (ISSN-L)
- OpenAlex
- W2105616338
- Cited by
- 98
- References
- 11
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.